AZD1480 |
Influence on protein activity |
Western Blot |
25.00 mg/kg |
spinal cord |
Mus musculus |
c57BL/6 |
STAT4 |
|
AZD1480 |
Influence on protein activity |
Western Blot |
25.00 mg/kg |
spinal cord |
Mus musculus |
c57BL/6 |
STAT3 |
|
AZD1480 |
Influence on protein activity |
Quantitative RT-PCR |
25.00 mg/kg |
spinal cord |
Mus musculus |
c57BL/6 |
|
|
AZD1480 |
Influence on PLP-induced Relapsing-Remitting EAE Disease |
Western Blot |
25.00 mg/kg |
spinal cord |
Mus musculus |
c57BL/6 |
STAT1 |
|
AZD1480 |
Influence on PLP-induced Relapsing-Remitting EAE Disease |
Western Blot |
25.00 mg/kg |
spinal cord |
Mus musculus |
c57BL/6 |
STAT3 |
|
AZD1480 |
Influence on PLP-induced Relapsing-Remitting EAE Disease |
Quantitative RT-PCR |
25.00 mg/kg |
spinal cord |
Mus musculus |
c57BL/6 |
|
|
AZD1480 |
Influence on PLP-induced Relapsing-Remitting EAE Disease |
Quantitative RT-PCR |
25.00 mg/kg |
spinal cord |
Mus musculus |
c57BL/6 |
|
|
AZD1480 |
Influence on PLP-induced Relapsing-Remitting EAE Disease |
Quantitative RT-PCR |
25.00 mg/kg |
spinal cord |
Mus musculus |
c57BL/6 |
|
|
AZD1480 |
Influence on the Priming and Expansion Phases of EAE |
Immunization |
25.00 mg/kg |
spinal cord |
Mus musculus |
c57BL/6 |
|
|